help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, C. F.
Right arrow Articles by Tanizawa, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C. F.
Right arrow Articles by Tanizawa, O.

Journal of Clinical Endocrinology & Metabolism, Vol 67, 1171-1177, Copyright © 1988 by Endocrine Society

ARTICLES

Changes in epidermal growth factor receptor and its messenger ribonucleic acid levels in human placenta and isolated trophoblast cells during pregnancy

CF Chen, H Kurachi, Y Fujita, N Terakawa, A Miyake and O Tanizawa
Department of Obstetrics and Gynecology, Osaka University Medical School, Japan.

We measured the amounts of epidermal growth factor receptor (EGFR) in plasma membrane fractions purified from early, middle, and term placentas and from isolated trophoblast cells, and the amounts of EGFR mRNA were measured in whole placentas. Binding studies were performed using [125I] human EGF as ligand; two classes (high and low) of binding sites were found in placental and trophoblast cell plasma membranes. Although dissociation constants (Kd) were not significantly different in placental plasma membranes from the three stages of pregnancy, the number of binding sites increased significantly during pregnancy. The mean numbers of binding sites were 0.72 +/- 0.18 (+/- SE), 1.02 +/- 0.10, and 1.89 +/- 0.21 pmol/mg protein (high affinity sites) in plasma membrane fractions from early, middle, and term whole placentas, respectively. A similar significant increase was found when the membranes were prepared from isolated trophoblast cells. At the same time, total cellular RNA was isolated, denatured, and blotted onto nitrocellulose membranes. Then, hybridization with 32P-labeled pE 7, a cDNA of EGFR, or 32P-labeled v-erb-B oncogene, autoradiography, and densitometry were performed. The EGFR mRNA increased proportionally to the changes in EGFR during pregnancy. These results indicate that EGF- binding sites and EGFR production increase in human placentas throughout the gestational period.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
Y. Okamoto, M. Sakata, K. Ogura, T. Yamamoto, M. Yamaguchi, K. Tasaka, H. Kurachi, M. Tsurudome, and Y. Murata
Expression and regulation of 4F2hc and hLAT1 in human trophoblasts
Am J Physiol Cell Physiol, January 1, 2002; 282(1): C196 - C204.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Y. Kamei, O. Tsutsumi, A. Yamakawa, Y. Oka, Y. Taketani, and J. Imaki
Maternal Epidermal Growth Factor Deficiency Causes Fetal Hypoglycemia and Intrauterine Growth Retardation in Mice: Possible Involvement of Placental Glucose Transporter GLUT3 Expression
Endocrinology, September 1, 1999; 140(9): 4236 - 4243.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society